Dhruv Texofab Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 2 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 50.09 Cr
About Dhruv Texofab
Dhruv Texofab Private Limited (DTPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 December 2022 (Two years and one month 19 days old ). Its registered office is in Surat, Gujarat, India.
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹50.09 Cr.
Abhishek Bansal and Aditya Bansal serve as directors at the Company.
Company Details
-
Location
Surat, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U17299GJ2022PTC137438
-
Company No.
137438
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
14 Dec 2022
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Dhruv Texofab?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhishek Bansal
|
Director | 14-Dec-2022 | Current |
|
Aditya Bansal
|
Director | 14-Dec-2022 | Current |
Financial Performance of Dhruv Texofab.
Dhruv Texofab Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dhruv Texofab?
Unlock access to Dhruv Texofab's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Uniexcel Polychem Private LimitedAbhishek Bansal and Aditya Bansal are mutual person
Charges (Loans)
₹50.09 Cr
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 30.09 Cr
- Others : 20.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Nov 2024 | Hdfc Bank Limited | ₹30.00 Cr | Open |
| 20 Oct 2023 | Others | ₹3.25 Cr | Open |
| 15 Jun 2023 | Hdfc Bank Limited | ₹0.92 M | Open |
| 03 Jun 2023 | Others | ₹16.75 Cr | Open |
How Many Employees Work at Dhruv Texofab?
Dhruv Texofab has a workforce of 0 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dhruv Texofab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dhruv Texofab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
